Harbin Gloria in $170 Million Deal to Acquire Huatuo Medical Science
February 21, 2014 at 10:56 AM EST
Harbin Gloria Pharma acquired Shanghai Huatuo Medical Science through a series of purchases with at least 75 shareholders. All together, Gloria paid 993.1 million RMB for a 90.9% stake in Huatuo, though it owns 98.9% of the company (it did not disclose the price on an 8% purchase). Huatuo has committed to producing profits of at least 106 million RMB in 2014. Gloria said the purchase price works out to a price/earnings ratio of 9.6, implying a purchase price of just over 1 billion RMB ($170 million). More details.... Stock Symbol: (SHE: 002437) Share this with colleagues: // //